EP Patent

EP1700611A1 — Device for treatment of disorders in the oral cavity, and manufacturing process for the same

Assigned to Nolabs AB · Expires 2006-09-13 · 20y expired

What this patent protects

A device and method for therapeutical treatment of disorders in the oral cavity and a process for manufacturing of said device is disclosed. The device being comprised of a nitric oxide (NO) eluting polymer. The nitric oxide (NO) eluting polymer is configured for eluting a therap…

USPTO Abstract

A device and method for therapeutical treatment of disorders in the oral cavity and a process for manufacturing of said device is disclosed. The device being comprised of a nitric oxide (NO) eluting polymer. The nitric oxide (NO) eluting polymer is configured for eluting a therapeutic dosage of nitric oxide (NO) when used in the oral cavity. The device allows for target treatment of infections or wounds in the oral cavity. The device comprising the nitric oxide (NO) eluting polymer is arranged to contact an infected area in the oral cavity, such that a therapeutic dose of nitric oxide is eluted from said nitric oxide eluting polymer to said area.

Drugs covered by this patent

Patent Metadata

Patent number
EP1700611A1
Jurisdiction
EP
Classification
Expires
2006-09-13
Drug substance claim
No
Drug product claim
No
Assignee
Nolabs AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.